Emergent BioSolutions Inc.
EBS- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001367644
In the last 90 days, Emergent BioSolutions Inc. insiders filed 0 open-market purchases and 1 sale; 194 institutions reported holding it in 13F filings for Q2 2026, worth $373.6M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Emergent BioSolutions Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 183
- −8 vs. Q1 2023
- Shares held
- 45.7M
- +1.46M (+3.3%) vs. Q1 2023
- Total value
- $336.2M
- −$129.0M (−27.7%) vs. Q1 2023
- New holders
- 20
- 59 more added
- Sold out
- 28
- 75 more reduced
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EBS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 194 | $373.6M |
| Q1 2026 | 190 | $360.7M |
| Q4 2025 | 183 | $536.5M |
| Q3 2025 | 169 | $352.5M |
| Q2 2025 | 161 | $240.9M |
| Q1 2025 | 161 | $176.1M |
| Q4 2024 | 156 | $332.0M |
| Q3 2024 | 140 | $264.5M |
| Q2 2024 | 141 | $207.5M |
| Q1 2024 | 121 | $90.8M |
| Q4 2023 | 134 | $98.2M |
| Q3 2023 | 163 | $140.8M |
| Q2 2023 | 183 | $336.2M |
| Q1 2023 | 192 | $465.3M |
| Q4 2022 | 198 | $545.8M |
| Q3 2022 | 211 | $852.4M |
| Q2 2022 | 233 | $1.28B |
| Q1 2022 | 254 | $1.72B |
| Q4 2021 | 254 | $1.86B |
| Q3 2021 | 277 | $2.23B |
| Q2 2021 | 290 | $2.82B |
| Q1 2021 | 340 | $4.14B |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Emergent BioSolutions Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ameritas Advisory Services, LLC | 0 | $0 | 0.00% | −800−100.0% | Sold out |
| Belpointe Asset Management LLC | 0 | $0 | 0.00% | −418−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −138−100.0% | Sold out |
| Arcadia Investment Advisors LLC | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| JFS Wealth Advisors, LLC | 0 | $0 | 0.00% | −29−100.0% | Sold out |
| Disciplined Investments, LLC | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| SJS Investment Consulting Inc. | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| AdvisorNet Financial, Inc | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Cary Street Partners Asset Management LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Schubert & Co | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −41−100.0% | Sold out |
| ETF Managers Group, LLC | – | – | – | – | Not filed |